Cognitive-Behavioral Therapy for Adults With ADHD: A Qualitative Study

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title:

Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: A Qualitative Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05037903
• Other study ID #: KI-2021-01663
• Status: Completed
• Phase: N/A
• Start date: July 1, 2021
• Est. completion date: August 31, 2022

Study information

• Verified date: February 2023
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a qualitative study of participants who have taken part in a randomized controlled trial (RCT) of a new treatment protocol based on cognitive-behavioral therapy for adults with attention deficit/hyperactivity disorder predominantly inattentive presentation. The purpose of the qualitative study is to explore participant perceptions of taking part in the RCT to further develop and improve the new treatment protocol.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: August 31, 2022
• Est. primary completion date: August 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Principal diagnosis of ADHD inattentive presentation

• 18 years of age or older

• If on medication, it needs to be well-established since three months, and

• Prior psycho-educational intervention

Exclusion Criteria:

• Intellectual impairment

• Substance use disorder

• Difficulties in adherence to medical or other treatment

• Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or

• Simultaneous psychological treatment

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Hyperkinesis

Intervention

Behavioral:
• Cognitive-behavioral therapy
Cognitive and behavioral interventions aimed at increasing behavioral activation, and reducing procrastination and inattentive symptoms.

Locations

Country	Name	City	State
Sweden	Stockholm Health Care Services, Region Stockholm	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative interview data	Participant responses based on questions posed in an interview	45-60 minutes